No Data
No Data
Express News | Mink Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report
MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report
Express News | MiNK Therapeutics Announced That It Has Regained Compliance With The Nasdaq Capital Market's Market Value Of Listed Securities Requirement
Express News | Mink Therapeutics Regains Compliance With Nasdaq Capital Market Requirement
MiNK Therapeutics Regains Compliance With Nasdaq Capital Market Requirement
MiNK Therapeutics, Inc. (INKT) Upgraded to Strong Buy: Here's What You Should Know
No Data
Seraphicall : Not running means buy
Trytosaveabit OP Seraphicall : I have to go through my notes to be sure. But it may be a decent swing trade. I believe there is to be some catalyst coming. Just can’t remember what/when off top of my mind? Grrr. Hehehe
Seraphicall Trytosaveabit OP : Do share with me when you recall too ya
Seraphicall Trytosaveabit OP : Thanks in advance